Form 8-K - Current report:
SEC Accession No. 0001104659-25-051336
Filing Date
2025-05-21
Accepted
2025-05-21 09:00:28
Documents
12
Period of Report
2025-05-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515781d1_8k.htm   iXBRL 8-K 23678
  Complete submission text file 0001104659-25-051336.txt   190853

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20250520.xsd EX-101.SCH 3026
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20250520_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20250520_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2515781d1_8k_htm.xml XML 3812
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 25971022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)